VALENCIA. Primero Salud, Ribera’s parent company and Centene’s branch in Spain and Europe, until 2022 when all its assets are acquired by the French company Vivalto Santeclosed 2021 with a profit of 34.7 million euros, compared to a loss of three million in the previous year. This is reflected in the company’s accounts, which marks 14 million in said outcome for the acquisition of Dénia department manager Marina Salud.
as i already guessed Valencia SquareThe acquisition of a 65% stake in DKV cost this. 16.2 million € River bank. an assessment very close to the figures considered at the time As the amount Generalitat can pay to realize Transition of Dénia Hospital to public administration. However, the liquidation of the department, which, according to the annotations in the accounts, is over 100 million Euros in favor of Generalitat, will need to be clarified with the administration.
In 2021, the company brought together the health departments of Torrevieja – reclaimed in 2021 – Vinalopó and Dénia, University Hospital Torrejón and Hospital Ribera Povisa. The company also has other divisions, such as a technological Futures or b2b purchasing centre. It also owns the Cialab laboratory in Alicante, the Santa Justa and Almendralejo health centers in Badajoz, and the Santo Domingo de Lugo Clinics, among others. The group also renewed the concession of the central laboratory of the Community of Madrid, URsalud, which serves six public hospitals in the region.
Last full year, it also acquired Hospital Ribera Juan Cardona in Ferrol and Ribera Hospital de Molina in Murcia. It also created two dedicated health divisions: Ribera Estética and Ribera Dent together Minds emotional health program. In total, nine hospitals, 71 health centers, a university Nursing school and an Occupational Health Education study center.
Outside of Spain, the company has a majority stake in the Slovak company Pro Diagnostic Group (PDG), the country’s leader in diagnostic imaging, and a stake in two hospital concessions in Peru. In addition, Ribera is one of the finalists in the Portuguese Government’s competition for the management of the Cascais public hospital through a concession. Thanks to their incorporation and increase in activity, the turnover increased by 30% to 659.6 million Euros.
with the liquidations
The deals with the Valencian management remain a headache for both the concessionaires and the Miguel Mínguez department. At the end of 2021, The liquidation process of 2010 for 2012, Holding Commission mixed in December 2021. In January 2022, remembered the beginning of the process settlement of the year 2016 Y 2017 Ribera Health II UTE.
On the date of the consolidated annual accounts, most closing process these placement in both concessions continue. Inside concessionaire Marina Salud I know Joint Commission held in January 2021 a most settlements for the 2014 fiscal years a 2016.”I know receives a solution proposal. A date of creation of consolidated annual accounts, this Replies are awaited most Conselleria de Sanitat is about the company’s claims filed in November 2021,” is included in its management report.
According to balances, in 2021 Primero Salud had a pending balance of €281 million to suppliers – mostly payments made to Valencia management – compared to 127.5 million a year earlier. However, it is an amount that may differ from that marked due to the usual contention between the administration and the dealers.
2022, year with new owner
Vivalto Santé’s entry into Ribera changes the strategy of Centene Corporation after the shock in the healthcare industry due to the covid pandemic, and above all withdrawal due to illness and the subsequent death of its founder and chairman, Michael Neidorffreplaced as CEO Sarah London. The focus of the North American company specializing in health insurance on the North American market explains why it ended its European adventure.
Managed by the Ribera group since October 2020. Elisa Tarazona duration Alberto de Rosa appointed as Europe CEO of Centeneis at the forefront of the North American multinational’s expansion into Europe. With Vivalto Santé joining, De Rosa will remain in the European group and leave Centene.
#Riberas #parent #company #Primero #Salud #closes #profit #million #million #acquire #Dénia